Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Peter Ljubenkov, Md

Clinical trials sponsored by Peter Ljubenkov, Md, explained in plain language.

Trials to join now! 1
Sort by
  • Could a pill slow language loss in rare dementia?

    Symptom relief Recruiting now

    This early-stage study tests whether an oral drug called Verdiperstat is safe and tolerable for people with semantic variant primary progressive aphasia (svPPA), a rare dementia that gradually destroys the ability to understand words and recognize objects. About 64 adults with sv…

    Phase: PHASE1 • Sponsor: Peter Ljubenkov, MD • Aim: Symptom relief

    Last updated May 15, 2026 11:56 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space